Cite
HARVARD Citation
Lee, A. et al. (2021). Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients. Scandinavian journal of rheumatology. pp. 469-474. [Online].